The use of ketogenic diets in children living with drug‐resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review
Journal of Human Nutrition and Dietetics · 2024
DOI: 10.1111/jhn.13324 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Human Nutrition and Dietetics, 2024. Verfasst von Tracy Cameron und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal Aberdeen Children's Hospital, NHS Grampian, Aberdeen, Scotland, UK. Hauptthemen laut MEDLINE: Diet, Ketogenic, Pyruvate Dehydrogenase Complex Deficiency Disease, Drug Resistant Epilepsy, Carbohydrate Metabolism, Inborn Errors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 346 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The ketogenic diet (KD) is a high fat, moderate protein and very low carbohydrate diet. It can be used as a medical treatment for drug‐resistant epilepsy (DRE), glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency. The aim of this scoping review was to map the KD literature, with a focus on epilepsy and associated metabolic conditions, to summarise the current evidence‐base and identify any gaps.
Methods
This review was conducted using JBI scoping review methodological guidance and the PRISMA extension for scoping reviews reporting guidance. A comprehensive literature search was conducted in September 2021 and updated in February 2024 using MEDLINE, CINAHL, AMED, EmBASE, CAB Abstracts, Scopus and Food Science Source databases.
Results
The initial search yielded 2721 studies and ultimately, data were extracted from 320 studies that fulfilled inclusion criteria for the review. There were five qualitative studies, and the remainder were quantitative, including 23 randomised controlled trials (RCTs) and seven quasi‐experimental studies. The USA published the highest number of KD studies followed by China, South Korea and the UK. Most studies focused on the classical KD and DRE. The studies key findings suggest that the KD is efficacious, safe and tolerable.
Conclusions
There are opportunities available to expand the scope of future KD research, particularly to conduct high‐quality RCTs and further qualitative research focused on the child's needs and family support to improve the effectiveness of KDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal Aberdeen Children's Hospital, NHS Grampian, Aberdeen, Scotland, UK.
- School of Health Sciences, Robert Gordon University, Aberdeen, Scotland, UK.
- Scottish Centre for Evidence-based, Multi-professional Practice: A JBI Centre of Excellence, Aberdeen, Scotland, UK.
ORCID-Profile: Tracy Cameron, Karen Allan, Kay Cooper
Förderung
- None
Zitieren
APA
Cameron, T., Allan, K., & Kay Cooper (2024). The use of ketogenic diets in children living with drug‐resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review. Journal of Human Nutrition and Dietetics. https://doi.org/10.1111/jhn.13324
Vancouver
Cameron T, Allan K, Kay Cooper. The use of ketogenic diets in children living with drug‐resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review. Journal of Human Nutrition and Dietetics. 2024. doi:10.1111/jhn.13324
BibTeX
@article{Cameron2024,
author = {Cameron, Tracy and Allan, Karen and Kay Cooper},
title = {The use of ketogenic diets in children living with drug‐resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review},
journal = {Journal of Human Nutrition and Dietetics},
year = {2024},
doi = {10.1111/jhn.13324}
}
EUVIMED